Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.47)
# 3,532
Out of 5,111 analysts
177
Total ratings
45.33%
Success rate
-1.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $8.38 | -4.48% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $195 → $205 | $167.90 | +22.10% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $97.72 | +19.73% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $90.91 | +4.50% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $554.58 | +17.21% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $11.89 | +0.93% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $125.04 | -24.02% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $79.02 | +7.57% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $45.91 | -67.33% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $288.73 | +18.80% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.48 | +464.52% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $19.05 | +151.97% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $85.32 | +19.55% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $92.95 | -37.60% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $16.98 | +17.79% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $66.37 | +97.38% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $126.86 | +4.84% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $351.69 | -37.44% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $124.87 | +202.71% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $8.38
Upside: -4.48%
iRhythm Technologies
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $167.90
Upside: +22.10%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $97.72
Upside: +19.73%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $90.91
Upside: +4.50%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $554.58
Upside: +17.21%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $11.89
Upside: +0.93%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $125.04
Upside: -24.02%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $79.02
Upside: +7.57%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $45.91
Upside: -67.33%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $288.73
Upside: +18.80%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.48
Upside: +464.52%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $19.05
Upside: +151.97%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $85.32
Upside: +19.55%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $92.95
Upside: -37.60%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $16.98
Upside: +17.79%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $66.37
Upside: +97.38%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $126.86
Upside: +4.84%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $351.69
Upside: -37.44%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $124.87
Upside: +202.71%